您当前的位置：
首页 >
文章列表页 >
Investigation on Mechanism of Modified Banxia Xiexintang in Improving Ovarian Dysfunction of PCOS-IR Rats by Inhibiting Ferroptosis via AMPK/FASN/GPX4 Signaling Pathway
更新时间：2026-03-03

    • Investigation on Mechanism of Modified Banxia Xiexintang in Improving Ovarian Dysfunction of PCOS-IR Rats by Inhibiting Ferroptosis via AMPK/FASN/GPX4 Signaling Pathway

    • “Based on the AMPK/FASN/GPX4 signaling pathway, experts have explored the mechanism by which Jiawei Banxia Xiexin Tang improves ovarian dysfunction in polycystic ovary syndrome with insulin resistance rats by inhibiting ferroptosis, providing new ideas for related treatments.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 32, Issue 7, Pages: 150-160(2026)

    • DOI：10.13422/j.cnki.syfjx.20260163    

      CLC： R242;R271.1;R856.2

    • Received：12 January 2026，

      Revised：2026-01-23，

      Accepted：26 January 2026，

      Online First：29 January 2026，

      Published：05 April 2026

    移动端阅览

  • BAI Donghan,TANG Ruying,LIN Longfei,et al.Investigation on Mechanism of Modified Banxia Xiexintang in Improving Ovarian Dysfunction of PCOS-IR Rats by Inhibiting Ferroptosis via AMPK/FASN/GPX4 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(07):150-160. DOI： 10.13422/j.cnki.syfjx.20260163.

  •  
  •  

0

Views

10

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Exploring Mechanism of Modified Banxia Xiexintang in Ameliorating Metabolic Disorders and Reproductive Function in PCOS-IR Rats Based on Metabolomics and Transcriptomics
Integrative Strategies of Traditional Chinese and Western Medicine for Polycystic Ovary Syndrome with Insulin Resistance： Synergistic Potentiation Mechanisms Based on Pathogenic Complementarity
Mechanism of Qingrun Prescription-containing Serum Improving Insulin Resistance in HepG2 Cells via Branched-chain α-keto Acid Dehydrogenase Regulation of Branched-chain Amino Acids （BCAAs）/mTOR Pathway

Related Author

LI Hui
TANG Ruying
LIU Hengchang
LIN Longfei
LIU Yuling
BU Xiangwei
HAO Xiaohui
ZHANG Runyun

Related Institution

Institute of Traditional Chinese Medicine Health Industry， China Academy of Chinese Medical Sciences
Graduate School of PLA General Hospital
Guang'anmen Hospital，China Academy of Chinese Medicine Sciences
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine（TCM）
Shunyi Hospital，Beijing TCM Hospital
0